Eupraxia Pharmaceuticals (EPRX) Change in Receivables (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Change in Receivables of -$26,168 in Q2 2026, compared with $112,771 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Change in Receivables (2023 - 2026) Analysis & Trends
On a TTM basis, Eupraxia Pharmaceuticals' Change in Receivables came in at $325,149 as of Jun 30, 2026, up 86.2% year-over-year; for FY2025, it came in at $431,449, up 325.5% from FY2024.
- Across earlier years, Change in Receivables came in at $101,389 in FY2024 (-2.2%), $103,710 in FY2023 and -$230,481 in FY2022.
- The Q2 2026 figure is the lowest quarterly Change in Receivables in data going back to Q1 2023.
- Per Business Quant, the preceding three quarters came in at $23,964 (Q1 2026), $334,631 (Q4 2025) and -$7,278 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 501,554.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 501,554.00 |
| Jun 30, 2026 | -26,168.00 |
| Mar 31, 2026 | 23,964.00 |
| Dec 31, 2025 | 334,631.00 |
| Sep 30, 2025 | -7,278.00 |
| Jun 30, 2025 | 112,771.00 |
| Mar 31, 2025 | -8,675.00 |
| Dec 31, 2024 | 20,085.00 |
| Sep 30, 2024 | 50,432.00 |
| Jun 30, 2024 | 13,671.00 |
| Mar 31, 2024 | 17,201.00 |
| Dec 31, 2023 | 83,213.00 |
| Sep 30, 2023 | -17,845.00 |
| Jun 30, 2023 | 36,654.00 |
| Mar 31, 2023 | 1,688.00 |
API Access
Eupraxia Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();